CJC-1295 No DAC Buying Guide for Researchers

CJC-1295 No DAC is purchased on documentation, not on marketing copy. A defensible wholesale order comes down to four things you can verify before money moves: compound identity confirmed analytically, purity confirmed by HPLC on the exact lot being shipped, a contaminant panel tied to that same lot number, and pricing you can see without a sales call. Real Peptides publishes batch-level certificates of analysis that applicants can check independently, tests to 99%+ HPLC purity under a 7-panel batch protocol, and fulfills from the US in 5–7 days. Everything below is research-use-only context for business buyers evaluating suppliers — it is not guidance for human use.

What the "No DAC" designation actually tells you

CJC-1295 appears in the literature in two distinct forms, and they are not interchangeable SKUs. The DAC version carries a drug affinity complex — a linker chemistry described in research as binding to serum albumin, which substantially extends circulation time in the models studied. The No DAC version, catalogued in much of the literature as mod GRF (1-29), omits that linker. It is a 29-amino-acid growth-hormone-releasing-hormone analog carrying amino acid substitutions that research indicates improve stability relative to native GHRH fragments.

For a buyer, the practical consequence is simple: these are two different line items with different molecular weights, different analytical signatures, and different price points. The most common ordering error in this category is not a counterfeit — it is a catalog mismatch, where a listing labeled one way ships documentation describing the other. Before a purchase order is issued, the molecular weight and sequence identity on the certificate should match the compound named on the invoice. If a supplier cannot produce that match on request, that is your answer about their inventory controls.

Naming compounds the problem further. The same compound circulates under several designations across supplier catalogs and forum discussions. Standardize internally on one naming convention, record the CAS or molecular weight alongside it in your purchasing system, and reconcile against that field on every receipt rather than against the label text.

Reading a certificate of analysis instead of trusting one

A certificate of analysis is only worth what its traceability is worth. The single most important attribute is whether the document is batch-specific — tied by lot number to the vials in the box you received — or whether it is a generic document reused across every unit of that SKU indefinitely. A generic COA tells you what a supplier once produced, not what they shipped you.

When you open a COA, work through it in this order. First, the lot number: it should appear on the document and on the physical label, and the two should agree. Second, the analytical methods: purity determined by high-performance liquid chromatography, identity confirmed by mass spectrometry. Third, the chromatogram itself — a real trace has labeled axes, retention times, and integration data, not a decorative image pasted into a template. Fourth, the contaminant panels: a serious batch protocol covers more than purity alone, extending to the classes of residue and contamination that manufacturing and lyophilization can introduce. Fifth, the testing party: an identified laboratory you can look up beats an unnamed "third-party lab" every time.

The red flags run in the other direction and are easy to spot once you know them. COAs released only after payment. COAs offered as a paid add-on. One undated document serving an entire catalog. Purity stated as a bare percentage with no method named. A lab name that returns nothing when searched. Any of these should stop an order, because each one moves the burden of proof off the supplier and onto you — and you are the party with the least ability to discharge it.

The questions that separate a supplier from a vendor

Most wholesale conversations in this category stay at the level of price per vial. The questions below sit underneath price and determine whether the price is even meaningful.

Run this list once per supplier, not once per order. The answers rarely change, and the exercise takes an afternoon — far less than the cost of discovering a documentation gap after you have built a catalog around it.

How wholesale pricing and order minimums generally work

Pricing in research peptides is structured, not arbitrary, and understanding the structure is most of the negotiation. Per-unit cost generally declines as committed volume rises, but programs differ in what they measure. Some tier on per-order volume, which rewards larger, less frequent purchases and pushes working capital into inventory. Others tier on cumulative or annual commitment, which lets a smaller buyer order more often without losing tier pricing. A third pattern blends across the catalog, so mixed-SKU orders count toward one threshold rather than forcing you to concentrate spend on a single compound.

Minimum order quantities follow the same logic. A per-SKU minimum constrains how many distinct compounds you can carry; a per-order minimum lets you diversify while still hitting the threshold. If you are building a catalog rather than restocking one compound, the difference is significant, and it is worth asking directly rather than inferring from a pricing page.

Avoid inventing a model based on advertised headline pricing. Actual margins and landed costs vary widely with volume, category, shipping, and how much of your own quality verification you absorb internally. The durable rule is that transparent tiers let you build a real cost model, and hidden pricing does not. When a supplier withholds pricing until a call, you are being asked to negotiate without a baseline — and the price you are quoted is a function of how you present, not of what the product costs.

One underrated variable: lot-to-lot consistency. A supplier who is slightly more expensive but whose batches read the same quarter after quarter costs you less in re-verification, less in inventory write-offs, and less in explaining variance to your own buyers than one whose documentation quality fluctuates.

Handling, storage and the paperwork that travels with the vial

Research peptides ship as lyophilized powder, and the unit of commerce is mass per vial — a CJC-1295 No DAC 10mg listing describes the mass in the vial and nothing more. Your receiving process should confirm three things on arrival: packaging integrity, label legibility including lot number, and agreement between the label, the packing document and the COA. Anything that fails those checks should be quarantined and raised with the supplier before it enters sellable stock.

Real Peptides does not provide reconstitution, preparation, or dosing guidance, because these compounds are supplied for laboratory research use only. That is a deliberate boundary, not an omission. Any concentration framework in a research setting is a matter of mass per volume, and it is determined by the receiving laboratory's own protocol and oversight — not by a supplier's marketing page. A vendor who volunteers preparation walkthroughs or usage instructions alongside product listings is creating a compliance exposure that lands partly on you the moment you resell their goods.

Licensing questions belong with your counsel, not your supplier

This section is informational and is not legal advice. Regulatory treatment of research compounds varies by jurisdiction, by business model, and by how a business represents what it sells, and no supplier can resolve that for you.

The productive move is to arrive at your attorney's office with the right questions rather than expecting a supplier to supply answers. Ask how your state board views your specific entity type and activity. Ask what registration, licensure, or record-keeping obligations may attach to purchasing, holding, or reselling research-use-only materials in your jurisdiction. Ask where responsibility sits for downstream representations made by anyone who buys from you. Ask what your labeling and marketing language can and cannot say. Ask how your business insurance responds to this category.

Treat every regulatory claim you encounter in supplier marketing as a question to verify rather than a settled fact — including confident assertions about what any agency does or does not permit. Check with your state board and your attorney before building a business model on any of it.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built around verification the buyer can perform independently. Compounds are tested to 99%+ HPLC purity, with a 7-panel batch testing protocol applied per lot rather than per SKU. Certificates of analysis are publicly verifiable — the buyer can check the lab results directly instead of taking a purity figure on faith or paying extra for the document that proves it. Fulfillment is US-based, with orders shipping in 5–7 days, which makes inventory planning a calculation rather than a guess. Wholesale access runs through a 3-step application, so qualified businesses see program pricing without a discovery-call gate.

Those are descriptions of process, not promises about outcomes. What they buy you is a shorter verification cycle: the documentation you would otherwise chase is already published, already lot-specific, and already yours to audit.

If your business is stocking research compounds and you have run the verification checklist above against your current sources, the Wholesale Partner Program application is the next step — it takes three steps to complete and opens program tiers to qualified businesses.

Researchers sourcing in this category often also stock adjacent compounds such as Ipamorelin 10mg and Tesamorelin 10mg, and the broader Growth Factor & Tissue Signaling Research and Popular Peptides collections show how the same batch testing standard applies across the catalog.